牛牛AI助理已提取核心訊息
John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 24, 2024, involving the acquisition of 67 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have reached a total of 400 shares. The transaction price and total value of the shares were not disclosed in the announcement.
John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 24, 2024, involving the acquisition of 67 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have reached a total of 400 shares. The transaction price and total value of the shares were not disclosed in the announcement.
與T2 Biosystems, Inc. [TTOO] 相關的約翰·斯佩爾澤爾三世於2024年2月24日執行了一項交易，涉及收購67股普通股。該交易被歸類爲'M'，表示行使或轉換衍生證券。在這筆交易之後，斯珀澤爾在T2 Biosystems的直接持股總量已達到400股。公告中未披露交易價格和股票總價值。
與T2 Biosystems, Inc. [TTOO] 相關的約翰·斯佩爾澤爾三世於2024年2月24日執行了一項交易，涉及收購67股普通股。該交易被歸類爲'M'，表示行使或轉換衍生證券。在這筆交易之後，斯珀澤爾在T2 Biosystems的直接持股總量已達到400股。公告中未披露交易價格和股票總價值。
有用
沒用
